HLA-E and neoplasm: Worse survival was associated with a high density of NKG2A+ tumor infiltrating NK cells and high levels of HLA-E in tumor tissues in patients with ovarian cancer, RCC, colorectal cancer, breast cancer, and lung cancer (51–53).